Beneficial effects of bisoprolol on the survival of hypertensive diastolic heart failure model rats

European Journal of Heart Failure

Volumn 10, Issue 5, 2008, Pages 446-453

  Nishio, Mayu ^a,b   Sakata, Yasushi ^a   Mano, Toshiaki ^a,b   Ohtani, Tomohito ^a,b   Takeda, Yasuharu ^a,b   Miwa, Takeshi ^b   Hori, Masatsugu ^a   Masuyama, Tohru ^c   Kondo, Takashi ^d   Yamamoto, Kazuhiro ^a,e  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b OSAKA UNIVERSITY   (Japan)

^c HYOGO COLLEGE OF MEDICINE   (Japan)

^d UNIVERSITY OF TOYAMA   (Japan)

^e OSAKA UNIVERSITY   (Japan)

Author keywords

blocker; Diastole; Heart failure; Inflammation; Oxidative stress

Indexed keywords

BISOPROLOL; CYTOKINE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; REACTIVE OXYGEN METABOLITE; SODIUM CHLORIDE;

ANALYTIC METHOD; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIOXIDANT ACTIVITY; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DETOXIFICATION; DRUG MEGADOSE; ELECTRON SPIN RESONANCE; HEART FAILURE; HEART LEFT VENTRICLE HYPERTROPHY; HEART MUSCLE; LOW DRUG DOSE; MALE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; SURVIVAL RATE;

ADRENERGIC BETA-ANTAGONISTS; ANIMALS; BISOPROLOL; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; HEART FAILURE, DIASTOLIC; HYPERTENSION; INFLAMMATION; MALE; OXIDATIVE STRESS; RATS; RATS, INBRED DAHL; SURVIVAL ANALYSIS;

EID: 42749091581     PISSN: 13889842     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejheart.2008.03.002     Document Type: Article

References (36)

1. Vasan R.S., Larson M.G., Benjamin E.J., et al. Congestive heart failure in subjects with normal versus reduced left ventricular ejection fraction: prevalence and mortality in a population-based cohort. J Am Coll Cardiol 33 (1999) 1948-1955
2. Zile M.R., Baicu C.F., and Gaasch W.H. Diastolic heart failure - abnormalities in active relaxation and passive stiffness of the left ventricle. N Engl J Med 350 (2004) 1953-1959
3. van Heerebeek L., Borbely A., Niessen H.W., et al. Myocardial structure and function differ in systolic and diastolic heart failure. Circulation 113 (2006) 1966-1973
4. Owan T.E., Hodge D.O., Herges R.M., et al. Trends in prevalence and outcome of heart failure with preserved ejection fraction. N Engl J Med 355 (2006) 251-259
5. Packer M., Bristow M.R., Cohn J.N., et al. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group. N Engl J Med 334 (1996) 1349-1355
6. MERIT-HF Study Group. Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF). Lancet 353 (1999) 2001-2007
7. CIBIS-II Investigators and Committees. The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial. Lancet 353 (1999) 9-13
8. Bergstrom A., Andersson B., Edner M., et al. Effect of carvedilol on diastolic function in patients with diastolic heart failure and preserved systolic function. Results of the Swedish Doppler-echocardiographic study (SWEDIC). Eur J Heart Fail 6 (2004) 453-461
9. Flather M.D., Shibata M.C., Coats A.J.S., et al. Randomized trial to determine the effect of nebivolol on mortality and cardiovascular hospital admission in elderly patients with heart failure (SENIORS). Eur Heart J 26 (2005) 215-225
10. Doi R., Masuyama T., Yamamoto K., et al. Development of different phenotypes of hypertensive heart failure: systolic versus diastolic failure in Dahl salt-sensitive rats. J Hypertens 18 (2000) 111-120
11. Yoshida J., Yamamoto K., Mano T., et al. AT1 receptor blocker added to ACE inhibitor provides benefits at advanced stage of hypertensive diastolic heart failure. Hypertension 43 (2004) 686-691
12. Nishio M., Sakata Y., Mano T., et al. Therapeutic effects of angiotensin II type1 receptor blocker at advanced stage of hypertensive diastolic heart failure. J Hypertens 25 (2007) 455-461
13. Sakata Y., Masuyama T., Yamamoto K., et al. Renin angiotensin system-dependent hypertrophy as a contributor to heart failure in hypertensive rats: different characteristics from renin angiotensin system-independent hypertrophy. J Am Coll Cardiol 37 (2001) 293-299
14. Masuyama T., Yamamoto K., Sakata Y., et al. Evolving changes in Doppler mitral flow velocity pattern in rats with hypertensive hypertrophy. J Am Coll Cardiol 36 (2000) 2333-2338
15. Kim S., Yoshiyama M., Izumi Y., et al. Effects of combination of ACE inhibitor and angiotensin receptor blocker on cardiac remodeling, cardiac function, and survival in rat heart failure. Circulation 103 (2001) 148-154
16. Kobayashi M., Machida N., Mitsuishi M., and Yamane Y. Beta-blocker improves survival, left ventricular function, and myocardial remodeling in hypertensive rats with diastolic heart failure. Am J Hypertens 17 (2004) 1112-1119
17. Yamamoto E., Kataoka K., Shintaku H., et al. Novel mechanism and role of angiotensin II induced vascular endothelial injury in hypertensive diastolic heart failure. Arterioscler Thromb Vasc Biol 27 (2007) 2569-2575
18. Sakata Y., Yamamoto K., Mano T., et al. Temocapril prevents transition to diastolic heart failure in rats even if initiated after appearance of LV hypertrophy and diastolic dysfunction. Cardiovasc Res 57 (2003) 757-765
19. Yoshida J., Yamamoto K., Mano T., et al. Angiotensin II type 1 and endothelin type A receptor antagonists differently modulate extracellular matrix regulatory system in diastolic heart failure. J Hypertens 21 (2003) 437-444
20. Valle I., Alvarez-Barrientos A., Arza E., Lamas S., and Monsalve M. PGC-1a regulates the mitochondrial antioxidant defense system in vascular endothelial cells. Cardiovasc Res 66 (2005) 562-573
21. Borniquel S., Valle I., Cadenas S., Lamas S., and Monsalve M. Nitric oxide regulates mitochondrial oxidative stress protection via the transcriptional coactivator PGC-1 alpha. FASEB J 20 (2006) E1216-E1227
22. Kojima Y., Kondo T., Zhao Q.L., Shoji M., and Futatsuya R. Protective effects of cimetidine on radiation-induced micronuclei and apoptosis in human peripheral blood lymphocytes. Free Radic Res 36 (2002) 255-263
23. Lechat P., Escolano S., Golmard J.L., et al. Prognostic value of bisoprolol-induced hemodynamic effects in heart failure during the Cardiac Insufficiency BIsoprolol Study (CIBIS). Circulation 96 (1997) 2197-2205
24. Ungerer M., Bohm M., Elce J.S., Erdmann E., and Lohse M.J. Altered expression of beta-adrenergic receptor kinase and beta-1-adrenergic receptors in the failing human heart. Circulation 87 (1993) 454-463
25. Goldman P.S., DeMaggio A.J., Hoekstra M.F., and Goodman R.H. The beta-adrenergic receptor kinase interacts with the amino terminus of the G protein beta subunit. Biochem Biophys Res Commun 240 (1997) 425-429
26. Bristow M.R., Gilbert E.M., Abraham W.T., et al. Carvedilol produces dose-related improvements in left ventricular function and survival in subjects with chronic heart failure. Circulation 94 (1996) 2807-2816
27. Dhalla A.K., Hill M.F., and Singal P.K. Role of oxidative stress in transition of hypertrophy to heart failure. J Am Coll Cardiol 28 (1996) 506-514
28. Hirotani S., Otsu K., Nishida K., et al. Involvement of nuclear factor-kappaB and apoptosis signal-regulating kinase 1 in G-protein-coupled receptor agonist-induced cardiomyocyte hypertrophy. Circulation 105 (2002) 509-515
29. Thaik C.M., Calderone A., Takahashi N., and Colucci W.S. Interleukin-1 beta modulates the growth and phenotype of neonatal rat cardiac myocytes. J Clin Invest 96 (1995) 1093-1099
30. Yue P., Massie B.M., Simpson P.C., and Long C.S. Cytokine expression increases in nonmyocytes from rats with postinfarction heart failure. Am J Physiol 275 (1998) H250-H258
31. Yamamoto E., Lai Z.F., Yamashita T., et al. Enhancement of cardiac oxidative stress by tachycardia and its critical role in cardiac hypertrophy and fibrosis. J Hypertens 24 (2006) 2057-2069
32. Yamamoto K., Masuyama T., Sakata Y., et al. Myocardial stiffness is determined by ventricular fibrosis, but not by compensatory or excessive hypertrophy in hypertensive heart. Cardiovasc Res 55 (2002) 76-82
33. Lechat P., Hulot J.S., Escolano S., et al. Heart rate and cardiac rhythm relationships with bisoprolol benefit in chronic heart failure in CIBIS II Trial. Circulation 103 (2001) 1428-1433
34. Mulder P., Barbier S., Chagraoui A., et al. Long-term heart rate reduction induced by the selective I(f) current inhibitor ivabradine improves left ventricular function and intrinsic myocardial structure in congestive heart failure. Circulation 109 (2004) 1674-1679
35. Ciobotaru V., Heimburger M., Louedec L., et al. Effect of long-term heart rate reduction by If-current inhibition on pressure-overload-induced heart failure in rats. J Pharmacol Exp Ther 324 (2008) 43-49
36. Hirawa N., Uehara Y., Numabe A., et al. Stimulating effects of atenolol on vasodepressor prostaglandin generation in spontaneously hypertensive rats. Clin Sci (Lond) 81 (1991) 499-507